GERON CORP Payments for Restructuring
GERON CORP (GERN) reported Payments for Restructuring of $2.77 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsForRestructuring · last filed 2026-08-05
- GERON CORP payments for restructuring for the quarter ending 2026-06-30 was $2.77M.
- GERON CORP payments for restructuring for the quarter ending 2026-03-31 was $13.53M.
- GERON CORP payments for restructuring for the quarter ending 2016-09-30 was $6.00K.
- GERON CORP payments for restructuring for the quarter ending 2016-06-30 was $16.00K.
- GERON CORP payments for restructuring for fiscal 2025 was $0.00.
- GERON CORP payments for restructuring for fiscal 2013 was $2.91M.
| Period end | Payments for Restructuring 3 month | Payments for Restructuring 6 month | Payments for Restructuring 9 month | Payments for Restructuring 12 month | Payments for Restructuring 13 month | Payments for Restructuring 16 month | Payments for Restructuring 19 month | Payments for Restructuring 22 month |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $2.77M 10-Q · filed 2026-08-05 | $16.30M derived: sum of 2 quarters · filed 2026-08-05 | ||||||
| 2026-03-31 | $13.53M 10-Q · filed 2026-08-05 | |||||||
| 2025-12-31 | $0.00 10-K · filed 2026-03-02 | |||||||
| 2016-12-31 | $988.00K 10-K · filed 2017-03-01 | |||||||
| 2016-09-30 | $6.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $22.00K derived: sum of 2 quarters · filed 2016-11-03 | $39.00K 10-Q · filed 2016-11-03 | $986.00K 10-Q · filed 2016-11-03 | ||||
| 2016-06-30 | $16.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | $33.00K 10-Q · filed 2016-08-03 | $980.00K 10-Q · filed 2016-08-03 | |||||
| 2016-03-31 | $17.00K 10-Q · filed 2016-05-05 | -$964.00K 10-Q · filed 2016-05-05 | ||||||
| 2014-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-05 | $9.00K derived: sum of 2 quarters · filed 2014-11-05 | $92.00K 10-Q · filed 2014-11-05 | $534.00K derived: sum of 4 quarters · filed 2014-11-05 | ||||
| 2014-06-30 | $9.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-11 | $92.00K 10-Q · filed 2014-08-11 | $534.00K derived: sum of 3 quarters · filed 2014-08-11 | $863.00K derived: sum of 4 quarters · filed 2014-08-11 | ||||
| 2014-03-31 | $83.00K 10-Q · filed 2014-05-01 | $525.00K derived: sum of 2 quarters · filed 2014-05-01 | $854.00K derived: sum of 3 quarters · filed 2014-05-01 | |||||
| 2013-12-31 | $442.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-17 | $771.00K derived: sum of 2 quarters · filed 2014-03-17 | $2.91M 10-K · filed 2014-03-17 | |||||
| 2013-09-30 | $329.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.47M 10-Q · filed 2013-11-07 | ||||||
| 2013-06-30 | $2.14M 10-Q · filed 2013-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B |